Marvin Caruthers

Prof. Marvin Caruthers

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2013 in Molecules
Verified
Journal Article
Open access
PDF file
SRSubhadeep Roy
Subhadeep Roy
MCMarvin Caruthers
Marvin Caruthers
The chemical synthesis of DNA and RNA is universally carried out using nucleoside phosphoramidites or H-phosphonates as synthons. This review focuses on the phosphorus chemistry behind these synthons and how it has been developed to generate procedures whereby yields per condensation approach 100% with very few side products. Additionally the synthesis and properties of certain DNA and RNA analogs that are modified at phosphorus will also be discussed. These analogs include boranephosphonates, metallophosphonates, and alkylboranephosphines.

1 January 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MCMarvin Caruthers
Marvin Caruthers
It is a great privilege to contribute to the Reflections essays. In my particular case, this essay has allowed me to weave some of my major scientific contributions into a tapestry held together by what I have learned from three colleagues (Robert Letsinger, Gobind Khorana, and George Rathmann) who molded my career at every important junction. To these individuals, I remain eternally grateful, as they always led by example and showed many of us how to break new ground in both science and biotechnology. Relative to my scientific career, I have focused primarily on two related areas. The first is methodologies we developed for chemically synthesizing DNA and RNA. Synthetic DNA and RNA continue to be an essential research tool for biologists, biochemists, and molecular biologists. The second is developing new approaches for solving important biological problems using synthetic DNA, RNA, and their analogs.

22 March 2011 in Biochemical Society Transactions
Verified
Journal Article
Closed access
MCMarvin Caruthers
Marvin Caruthers
Current methodologies used to synthesize DNA and RNA are reviewed. These focus on using controlled pore glass and microarrays on glass slides.

31 August 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HLHeera K. Langner
Heera K. Langner
KJKatarzyna Jastrzebska
Katarzyna Jastrzebska
MCMarvin Caruthers
Marvin Caruthers

29 August 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
BLBao T. Le
Bao T. Le
SPSibasish Paul
Sibasish Paul
KJKatarzyna Jastrzebska
Katarzyna Jastrzebska
HLHeera Langer
Heera Langer
MCMarvin Caruthers
Marvin Caruthers
RVRakesh Naduvile Veedu
Rakesh Naduvile Veedu
Recent advances in drug development have seen numerous successful clinical translations using synthetic antisense oligonucleotides (ASOs). However, major obstacles, such as challenging large-scale production, toxicity, localization of oligonucleotides in specific cellular compartments or tissues, and the high cost of treatment, need to be addressed. Thiomorpholino oligonucleotides (TMOs) are a recently developed novel nucleic acid analog that may potentially address these issues. TMOs are composed of a morpholino nucleoside joined by thiophosphoramidate internucleotide linkages. Unlike phosphorodiamidate morpholino oligomers (PMOs) that are currently used in various splice-switching ASO drugs, TMOs can be synthesized using solid-phase oligonucleotide synthesis methodologies. In this study, we synthesized various TMOs and evaluated their efficacy to induce exon skipping in a Duchenne muscular dystrophy (DMD) in vitro model using H2K mdx mouse myotubes. Our experiments demonstrated that TMOs can efficiently internalize and induce excellent exon 23 skipping potency compared with a conventional PMO control and other widely used nucleotide analogs, such as 2′-O-methyl and 2′-O-methoxyethyl ASOs. Notably, TMOs performed well at low concentrations (5–20 nM). Therefore, the dosages can be minimized, which may improve the drug safety profile. Based on the present study, we propose that TMOs represent a new, promising class of nucleic acid analogs for future oligonucleotide therapeutic development.

4 September 2020 in Accounts of Chemical Research
Verified
Journal Article
Closed access
PKPawan Kumar
Pawan Kumar
MCMarvin Caruthers
Marvin Caruthers